We bring you the latest news from the healthcare about the health care in the United Kingdom. Do your have news for us? Contact the editor. Watch also this special movie.

vrijdag 10 november 2017

Neuropsychopharmacology - Table of Contents alert Volume 42 Issue 13

If you are unable to see the message below, click here to view.
Neuropsychopharmacology
TABLE OF CONTENTS

Volume 42, Issue 13 (December 2017)

In this issue
Correspondence
Commentary
Original Articles
Corrigendum
In Memoriam
 
Follow NPP on Facebook Facebook

Follow NPP on Twitter Twitter

Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe

Correspondence

Top

Failure to Replicate an Association of a LINE-1 Element in ERI1 Exoribonuclease Family Member 3 (ERI3) with Schizophrenia

Glenn A Doyle and Wade H Berrettini

Neuropsychopharmacology 2017 42: 2471; 10.1038/npp.2017.145

Full Text

Commentary

Top

Microglia Activation in Subjects at Risk for Psychosis: Fact or Fiction?

Patricio O'Donnell

Neuropsychopharmacology 2017 42: 2472-2473; advance online publication, August 17, 2017; 10.1038/npp.2017.179

Full Text

Original Articles

Top

Imaging Microglial Activation in Individuals at Clinical High Risk for Psychosis: an In Vivo PET Study with [18F]FEPPA

Sina Hafizi, Tania Da Silva, Cory Gerritsen, Michael Kiang, R Michael Bagby, Ivana Prce, Alan A Wilson, Sylvain Houle, Pablo M Rusjan and Romina Mizrahi

Neuropsychopharmacology 2017 42: 2474-2481; advance online publication, June 12, 2017; 10.1038/npp.2017.111

Abstract | Full Text

Dose-Related Effects of Adjunctive Ketamine in Taiwanese Patients with Treatment-Resistant Depression

Tung-Ping Su, Mu-Hong Chen, Cheng-Ta Li, Wei-Chen Lin, Chen-Jee Hong, Ralitza Gueorguieva, Pei-Chi Tu, Ya-Mei Bai, Chih-Ming Cheng and John H Krystal

Neuropsychopharmacology 2017 42: 2482-2492; advance online publication, May 11, 2017; 10.1038/npp.2017.94

Abstract | Full Text

Entorhinal Cortical Deep Brain Stimulation Rescues Memory Deficits in Both Young and Old Mice Genetically Engineered to Model Alzheimer’s Disease

Frances Xia, Adelaide Yiu, Scellig S D Stone, Soojin Oh, Andres M Lozano, Sheena A Josselyn and Paul W Frankland

Neuropsychopharmacology 2017 42: 2493-2503; advance online publication, May 25, 2017; 10.1038/npp.2017.100

Abstract | Full Text

Intranasal Lactoferrin Enhances α-Secretase-Dependent Amyloid Precursor Protein Processing via the ERK1/2-CREB and HIF-1α Pathways in an Alzheimer’s Disease Mouse Model

Chuang Guo, Zhao-Hui Yang, Shuai Zhang, Rui Chai, Han Xue, Yan-Hui Zhang, Jia-Yi Li and Zhan-You Wang

Neuropsychopharmacology 2017 42: 2504-2515; advance online publication, January 12, 2017; 10.1038/npp.2017.8

Abstract | Full Text

Associations of the Intellectual Disability Gene MYT1L with Helix–Loop–Helix Gene Expression, Hippocampus Volume and Hippocampus Activation During Memory Retrieval

Agnieszka Kepa, Lourdes Martinez Medina, Susanne Erk, Deepak P Srivastava, Alinda Fernandes, Roberto Toro, Sabine Lévi, Barbara Ruggeri, Cathy Fernandes, Franziska Degenhardt, Stephanie H Witt, Andreas Meyer-Lindenberg, Jean-Christophe Poncer, Jean-Luc Martinot, Marie-Laure Paillère Martinot, Christian P Müller, Andreas Heinz, Henrik Walter, Gunter Schumann and Sylvane Desrivières

Neuropsychopharmacology 2017 42: 2516-2526; advance online publication, May 4, 2017; 10.1038/npp.2017.91

Abstract | Full Text

The BigLEN-GPR171 Peptide Receptor System Within the Basolateral Amygdala Regulates Anxiety-Like Behavior and Contextual Fear Conditioning

Erin N Bobeck, Ivone Gomes, Darlene Pena, Kirstie A Cummings, Roger L Clem, Mihaly Mezei and Lakshmi A Devi

Neuropsychopharmacology 2017 42: 2527-2536; advance online publication, April 20, 2017; 10.1038/npp.2017.79

Abstract | Full Text

β-Adrenoceptor Blockade in the Basolateral Amygdala, But Not the Medial Prefrontal Cortex, Rescues the Immediate Extinction Deficit

Thomas F Giustino, Jocelyn R Seemann, Gillian M Acca, Travis D Goode, Paul J Fitzgerald and Stephen Maren

Neuropsychopharmacology 2017 42: 2537-2544; advance online publication, May 2, 2017; 10.1038/npp.2017.89

Abstract | Full Text

Generalization of Extinguished Fear to Untreated Fear Stimuli after Exposure

Friederike Preusser, Jürgen Margraf and Armin Zlomuzica

Neuropsychopharmacology 2017 42: 2545-2552; advance online publication, June 7, 2017; 10.1038/npp.2017.119

Abstract | Full Text

Co-Activation of Metabotropic Glutamate Receptor 3 and Beta-Adrenergic Receptors Modulates Cyclic-AMP and Long-Term Potentiation, and Disrupts Memory Reconsolidation

Adam G Walker, Douglas J Sheffler, Andrew S Lewis, Jonathan W Dickerson, Daniel J Foster, Rebecca K Senter, Mark S Moehle, Xiaohui Lv, Branden J Stansley, Zixiu Xiang, Jerri M Rook, Kyle A Emmitte, Craig W Lindsley and P Jeffrey Conn

Neuropsychopharmacology 2017 42: 2553-2566; advance online publication, June 30, 2017; 10.1038/npp.2017.136

Abstract | Full Text

A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Comparison Design Trial of Adjunctive Riluzole for Treatment-Resistant Major Depressive Disorder

Sanjay J Mathew, Ralitza Gueorguieva, Cynthia Brandt, Maurizio Fava and Gerard Sanacora

Neuropsychopharmacology 2017 42: 2567-2574; advance online publication, May 29, 2017; 10.1038/npp.2017.106

Abstract | Full Text

Brain Tissue Pulsatility is Increased in Midlife Depression: a Comparative Study Using Ultrasound Tissue Pulsatility Imaging

Thomas Desmidt, Bruno Brizard, Paul-Armand Dujardin, Redouane Ternifi, Jean-Pierre Réméniéras, Frédéric Patat, Frédéric Andersson, Jean-Philippe Cottier, Emilie Vierron, Valérie Gissot, Kang Kim, Howard Aizenstein, Wissam El-Hage and Vincent Camus

Neuropsychopharmacology 2017 42: 2575-2582; advance online publication, June 6, 2017; 10.1038/npp.2017.113

Abstract | Full Text

Associations Between Daily Affective Instability and Connectomics in Functional Subnetworks in Remitted Patients with Recurrent Major Depressive Disorder

Michelle N Servaas, Harriëtte Riese, Remco J Renken, Marieke Wichers, Jojanneke A Bastiaansen, Caroline A Figueroa, Hanneke Geugies, Roel JT Mocking, Linda Geerligs, Jan-Bernard C Marsman, André Aleman, Aart H Schene, Robert A Schoevers and Henricus G Ruhé

Neuropsychopharmacology 2017 42: 2583-2592; advance online publication, March 31, 2017; 10.1038/npp.2017.65

Abstract | Full Text

Treatment of Bipolar Depression with Deep TMS: Results from a Double-Blind, Randomized, Parallel Group, Sham-Controlled Clinical Trial

Diego F Tavares, Martin L Myczkowski, Rodrigo L Alberto, Leandro Valiengo, Rosa M Rios, Pedro Gordon, Bernardo de Sampaio-Junior, Izio Klein, Carlos G Mansur, Marco Antonio Marcolin, Beny Lafer, Ricardo A Moreno, Wagner Gattaz, Zafiris J Daskalakis and André R Brunoni

Neuropsychopharmacology 2017 42: 2593-2601; advance online publication, February 1, 2017; 10.1038/npp.2017.26

Abstract | Full Text

Analysis of LINE-1 Elements in DNA from Postmortem Brains of Individuals with Schizophrenia

Glenn A Doyle, Richard C Crist, Emre T Karatas, Matthew J Hammond, Adam D Ewing, Thomas N Ferraro, Chang-Gyu Hahn and Wade H Berrettini

Neuropsychopharmacology 2017 42: 2602-2611; advance online publication, June 6, 2017; 10.1038/npp.2017.115

Abstract | Full Text

Cognitive Characterization of Schizophrenia Risk Variants Involved in Synaptic Transmission: Evidence of CACNA1C's Role in Working Memory

Donna Cosgrove, Omar Mothersill, Kimberley Kendall, Bettina Konte, Denise Harold, Ina Giegling, Annette Hartmann, Alex Richards, Kiran Mantripragada, The Wellcome Trust Case Control Consortium, Michael J Owen, Michael C O’Donovan, Michael Gill, Dan Rujescu, James Walters, Aiden Corvin, Derek W Morris and Gary Donohoe

Neuropsychopharmacology 2017 42: 2612-2622; advance online publication, June 13, 2017; 10.1038/npp.2017.123

Abstract | Full Text

Data-Driven Subgroups in Depression Derived from Directed Functional Connectivity Paths at Rest

Rebecca B Price, Kathleen Gates, Thomas E Kraynak, Michael E Thase and Greg J Siegle

Neuropsychopharmacology 2017 42: 2623-2632; advance online publication, May 12, 2017; 10.1038/npp.2017.97

Abstract | Full Text

Single-Dose Memantine Improves Cortical Oscillatory Response Dynamics in Patients with Schizophrenia

Gregory A Light, Wen Zhang, Yash B Joshi, Savita Bhakta, Jo A Talledo and Neal R Swerdlow

Neuropsychopharmacology 2017 42: 2633-2639; advance online publication, April 20, 2017; 10.1038/npp.2017.81

Abstract | Full Text

Predictors of Naltrexone Response in a Randomized Trial: Reward-Related Brain Activation, OPRM1 Genotype, and Smoking Status

Joseph P Schacht, Patrick K Randall, Patricia K Latham, Konstantin E Voronin, Sarah W Book, Hugh Myrick and Raymond F Anton

Neuropsychopharmacology 2017 42: 2640-2653; advance online publication, April 14, 2017; 10.1038/npp.2017.74

Abstract | Full Text

Corrigendum

Top

Predictors of Naltrexone Response in a Randomized Trial: Reward-Related Brain Activation, OPRM1 Genotype, and Smoking Status

Joseph P Schacht, Patrick K Randall, Patricia K Latham, Konstantin E Voronin, Sarah W Book, Hugh Myrick and Raymond F Anton

Neuropsychopharmacology 2017 42: 2654; 10.1038/npp.2017.185

Full Text

In Memoriam

Top

Steven H Ferris

John Rotrosen, Raymond T Bartus and Samuel Gershon

Neuropsychopharmacology 2017 42: 2655; 10.1038/npp.2017.184

Full Text

Irwin J Kopin

David S Goldstein and David R Sibley

Neuropsychopharmacology 2017 42: 2656; 10.1038/npp.2017.208

Full Text

Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Neuropsychopharmacology. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature